Sanofi India (BOM:500674) Asset Impairment Charge : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1991. Start your Free Trial

What is Sanofi India Asset Impairment Charge?

Sanofi India's Asset Impairment Charge for the three months ended in Mar. 2025 was ₹0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Sanofi India Asset Impairment Charge Historical Data

The historical data trend for Sanofi India's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Asset Impairment Charge Chart

Sanofi India Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Impairment Charge

Get a 7-Day Free Trial

Sanofi India Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Sanofi India Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Sanofi India Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Sanofi India's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (BOM:500674) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

SANOFI:India

Address

Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072

Website

https://www.sanofiindialtd.com

Sanofi India Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It focuses on a range of therapeutic areas, including diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines, among others, and sells its products through independent distributors predominantly in India. The company's products are manufactured in different types of dosage forms, including tablets, capsules (hard and soft), Eye/Ear drops, ampoules, vials, creams, and ointments, and are marketed under different brand names such as Soframycin, Lantus, Cardace, Soliqua, Solian, Thyrogen, Telcite, Zolineg, etc. Geographically, the company generates a majority of its revenue from India, followed by Singapore, and other export markets.

Sanofi India Headlines

No Headlines